DR Robin Smith CEO of Neostem Inc (AMEX:NBS)

.
.
.

NeoStem continues to develop and build on its core capabilities in cell therapy to capitalize on the paradigm shift that we see occurring in medicine. In particular, we anticipate that cell therapy will have a larger role in the fight against chronic disease and in lessening the economic burden that these diseases pose to modern society. Our January 2011 acquisition of Progenitor Cell Therapy, LLC (“PCT”) provides NeoStem with a foundation in both manufacturing and regulatory affairs expertise. We believe this expertise, coupled with our existing research capabilities and collaborative, will allow us to achieve our mission of becoming a premier cell therapy company.

canadian pharmacy

1 Comments

Click here to cancel reply.

The Stock Radio ("TSR") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of TSR may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. TSR, the authors, the publisher, and all affiliates of TSR assume no responsibility or liability for your trading and investment results. Factual statements on the TSR's website, or in its publications, are made as of the date stated and are subject to change without notice. For TSR full disclaimer and disclosure go to our disclaimer page. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by TSR are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of TSR's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on TSR's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

DR Robin Smith CEO of Neostem Inc (AMEX:NBS)

1 Comments

Leave a Comment